Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Stock Price & Analysis

6826 Stock Chart & Stats

HK$15.63-HK$0.43(-2.68%)
At close: 4:00 PM GMT+8
HKD 15.5HKD 16HKD 16.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
HKD 15.63 - HKD 16.28
52-Week Range
HKD 15.02 - HKD 28.26
Previous Close
HKD 16.06
Volume
220.22K
Average Volume (3M)
70.40K
Market Cap
HKD 7.12B
Enterprise Value
HKD 1.64B
Total Cash (Recent Filing)
HKD 2.32B
Total Debt (Recent Filing)
HKD 432.72M
Price to Earnings (P/E)
58.7
Beta
0.65
Next Earnings
Mar 22, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 04, 2026
Dividend Yield
6.25%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Debt-to-equity of about 0.07–0.08 indicates conservative financing and substantial balance-sheet flexibility. Low leverage reduces interest and refinancing pressure, helping the company withstand earnings volatility and preserve capacity to invest in its medical-device portfolio.

Positive Cash Generation

Positive operating cash flow since 2023 and improving TTM free cash flow show that the business continues to convert operations into cash. This supports internally funded investment, strengthens financial resilience, and reduces reliance on additional borrowing or equity issuance.

Diversified Medical Portfolio

The company serves several medical-device and biopharmaceutical applications rather than relying on one product category. Its ophthalmology, aesthetics, orthopedics, and tissue-repair portfolio provides multiple avenues for durable demand and broader commercialization opportunities.

Bears Say

Revenue Contraction

Recent revenue contraction marks a clear slowdown from the company’s stronger 2021–2023 growth period. Sustained weakness in the top line could limit operating leverage, reduce funds available for product development, and make future earnings recovery more dependent on renewed demand.

Sharp Margin Compression

The steep decline in net margin shows that profitability has weakened materially even though the company remains profitable. Lower earnings conversion reduces resilience, limits reinvestment capacity, and makes the business more sensitive to further revenue pressure or operating-cost changes.

Uneven Cash Conversion

Although recent cash generation is positive, the history of negative free cash flow and only moderate TTM conversion from net income indicate uneven cash quality. This can constrain the reliability of internally funded growth and complicate capital allocation during weaker earnings periods.

Shanghai Haohai Biological Technology Co., Ltd. Class H News

6826 FAQ

What was Shanghai Haohai Biological Technology Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Haohai Biological Technology Co., Ltd. Class H lowest stock price was HK$15.02 and its highest was HK$28.26 in the past 12 months.
What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap is HK$7.12B.
When is Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Shanghai Haohai Biological Technology Co., Ltd. Class H’s earnings last quarter?
Shanghai Haohai Biological Technology Co., Ltd. Class H released its earnings results on Oct 23, 2026. The company reported HK$0.258 earnings per share for the quarter.
Is Shanghai Haohai Biological Technology Co., Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Shanghai Haohai Biological Technology Co., Ltd. Class H pay dividends?
Shanghai Haohai Biological Technology Co., Ltd. Class H pays a Quarterly dividend of HK$0.289 which represents an annual dividend yield of 6.25%. See more information on Shanghai Haohai Biological Technology Co., Ltd. Class H dividends here
What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Haohai Biological Technology Co., Ltd. Class H have?
Shanghai Haohai Biological Technology Co., Ltd. Class H has 34,780,340 shares outstanding.
What happened to Shanghai Haohai Biological Technology Co., Ltd. Class H’s price movement after its last earnings report?
Shanghai Haohai Biological Technology Co., Ltd. Class H reported an EPS of HK$0.258 in its last earnings report. Following the earnings report the stock price went up 1.687%.
Which hedge fund is a major shareholder of Shanghai Haohai Biological Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6826
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology